Most Read Articles
2 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.

Expression of many miRNAs altered in Alzheimer’s disease

19 Dec 2019
Can Alzheimer’s disease finally be cured?

Several microRNAs (miRNAs) are differentially expressed in the brain, cerebrospinal fluid and blood in Alzheimer’s disease (AD) and may help improve early detection of the disease, reports a recent meta-analysis.

Researchers retrieved 107 publications from the PubMed database, corresponding to 147 independent datasets. Majority of the miRNA expression data were collected from brain tissue (n=60), followed by blood (n=53) and cerebrospinal fluid (n=32) samples. Fifteen datasets reported findings for more than one tissue type.

A total of 260 meta-analyses were carried out on data from brain-derived specimens. Ten percent (n=25) showed study-wide differential expression that achieved statistical significance. Twelve miRNAs were upregulated, while the remaining 13 had their expression levels reduced. Nine miRNAs were classified as having strong evidence due to the consistency of effect across different studies.

Sixty-six meta-analyses were performed on miRNAs extracted from cerebrospinal fluid samples. Of these, five (8 percent) were differentially expressed in AD patients, each with consistent evidence across studies. All five miRNAs were found to be downregulated in patients vs controls.

Blood samples yielded the greatest number of putative miRNA biomarkers. Of the 135 meta-analyses, 24 percent (n=32) showed significantly different expression levels in AD patients; 19 were downregulated, while the rest were enriched. Twenty-one had strong supporting evidence.

Notably, five miRNAs were found to have significantly different expression levels in both brain-derived and blood samples, three of which were upregulated.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.